T. Welte (Hannover, Germany), A. Liapikou (Athens, Greece)
Introduction
T. Welte (Hannover, Germany), A. Liapikou (Athens, Greece)
|  |
Investigating neutrophil AMPK activity in COVID-19 and pneumonia
Y. Giam (Dundee (Angus), United Kingdom), M. Long (Dundee (Angus), United Kingdom), L. Delgado (Dundee (Angus), United Kingdom), H. Abo-Leyah (Dundee (Angus), United Kingdom), H. Keir (Dundee (Angus), United Kingdom), T. Pembridge (Dundee (Angus), United Kingdom), R. Hull (Sheffield, United Kingdom), A. Gilmour (Dundee (Angus), United Kingdom), C. Hughes (Dundee (Angus), United Kingdom), H. Richardson (Dundee (Angus), United Kingdom), D. Cassidy (Dundee (Angus), United Kingdom), A. Shoemark (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom)
|    |
Clinical efficacy between cefoperazone-sulbactam and prolonged infusion of piperacillin-tazobactam in the treatment of severe CAP, HAP and VAP: a retrospective multicenter cohort study
C. Sun (Taipei, Taiwan), W. Chen (Taipei, Taiwan)
| |
The efficacy of telavancin in comparison to linezolid on endotracheal tube biofilm in pigs with MRSA pneumonia>
K. KIAROSTAMI (Barcelona, Spain), D. Battaglini (Genoa, Italy), A. Motos (Barcelona, Spain), L. Bueno Freire (Barcelona, Spain), A. Soler Comas (Barcelona, Spain), H. Yang (Barcelona, Spain), M. Yang (Barcelona, Spain), F. Pagliara (Genoa, Italy), E. Aguilera Xiol (Barcelona, Spain), A. Meli (Barcelona, Spain), J. Bobi (Barcelona, Spain), T. Senussi Testa (Genoa, Italy), F. Idone (Rome, Italy), M. Rigol (Barcelona, Spain), G. Li Bassi (Barcelona, Spain), L. Fernández-Barat (Barcelona, Spain), A. Torres (Barcelona, Spain)
| |
Machine learning for mortality prediction in community-acquired pneumonia emergency admissions
D. Lozano-Rojas (Leicester, United Kingdom), A. Mcewan (Leicester, United Kingdom), G. Woltmann (Leicester, United Kingdom), R. Free (Leicester, United Kingdom)
| |
Patients with COVID-19 versus non-COVID-19 community-acquired pneumonia
A. Liapikou (Athens, Greece), H. Milionis (Ioannina, Greece), A. Liontos (Ioannina, Greece), V. Tsimihodimos (Ioannina, Greece), A. Konstantinidis (Ioannina, Greece), K. Exarchos (Ioannina, Greece), K. Gartzonika (Ioannina, Greece), C. Kittas (Ioannina, Greece), G. Baxevanos (Ioannina, Greece), T. Tzimas (Ioannina, Greece), E. Chrysostomou (Ioannina, Greece), N. Zotos (Ioannina, Greece), L. Papageorgiou (Ioannina, Greece), C. Terrovitou (Kavala, Greece), D. Daniilidis (Kavala, Greece), C. Triantafyllidis (Kavala, Greece), T. Argiriadou (Kavala, Greece), A. Chli (Kavala, Greece), E. Tsouchnika (Kavala, Greece), V. Kossyvaki (Athens, Greece), J. Skiadas (Athens, Greece), D. Menegas (Athens, Greece), C. Méndez (Madrid, Spain), C. Schwarz (Vienna, Austria), E. Begier (Collegeville, United States), B. D. Gessner (Collegeville, United States), M. Toumbis (Athens, Greece), S. Egnatia Group (Athens, Greece), A. Konstantinidis (Ioannina, Greece)
| |
Impact of severe lymphopenia on outcome of patients with pneumonia and positive pneumococcal urinary antigen
L. Ruiz Iturriaga (Barakaldo (Vizcaya), Spain), L. Serrano Fernández (Barakaldo (Vizcaya), Spain), S. Pérez-Fernández (Barakaldo (Vizcaya), Spain), S. Castro Quintas (Barakaldo (Vizcaya), Spain), A. Urrutia Gajate (Barakaldo (Vizcaya), Spain), B. González Quero (Barakaldo (Vizcaya), Spain), A. Rezola Carasusan (Barakaldo (Vizcaya), Spain), A. Artaraz Ereño (Galdakao (Vizcaya), Spain), A. Gómez Bonilla (Barakaldo (Vizcaya), Spain), P. España Yandiola (Galdakao (Vizcaya), Spain), R. Zalacain Jorge (Barakaldo (Vizcaya), Spain)
| |
Development of AI models to predict mortality and long-term hospitalization in pneumonia
T. Furukawa (Nagoya (Aichi), Japan), S. Oyama (Nagoya (Aichi), Japan), K. Sato (Nagoya (Aichi), Japan), S. Misawa (Tokyo, Japan), R. Kano (Tokyo, Japan), H. Yarimizu (Tokyo, Japan), Y. Shiratori (Nagoya (Aichi), Japan)
| |
Neutrophils in elderly hospitalised community acquired pneumonia patients are immature and migrate inaccurately
A. Faniyi (Birmingham, United Kingdom), F. Grudzinska (Birmingham, United Kingdom), O. Thein (Birmingham, United Kingdom), K. Belchamber (Birmingham, United Kingdom), J. Patel (Birmingham, United Kingdom), D. Parekh (Birmingham, United Kingdom), A. Scott (Birmingham, United Kingdom), E. Sapey (Birmingham, United Kingdom), D. Thickett (Birmingham, United Kingdom), S. Thein (Birmingham (West Midlands), United Kingdom)
| |
The diagnostic and prognostic role of plasminogen activator inhibitor-1 (PAI-1) in hospitalized patients with pneumonias of different etiologies
K. Bielosludtseva (Dniepropetrovsk, Ukraine)
| |
Late Breaking Abstract - Are undernutrition and obesity associated with poor outcomes after hospitalization with community-acquired pneumonia – a prospective cohort study.
M. Hegelund (Hillerød, Denmark), C. Ryrsø (Hillerød, Denmark), C. Ritz (Copenhagen, Denmark), A. Dungu (Hillerød, Denmark), R. Krogh-Madsen (Hvidovre, Denmark), B. Lindegaard (Hillerød, Denmark), D. Faurholt-Jepsen (Copenhagen, Denmark)
| |